CATT study demonstrates equivalency between Avastin (bevacizumab) and Lucentis (ranibizumab) at year
In a long-awaited pronouncement from the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) Research Group, 1 year study results have shown that the monthly… Read More »CATT study demonstrates equivalency between Avastin (bevacizumab) and Lucentis (ranibizumab) at year